Akira Hishida
Overview
Explore the profile of Akira Hishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
218
Citations
6106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe K, Hasegawa H, Katoh J, Hayashi Y, Saku I, Ohshima K, et al.
Clin Exp Nephrol
. 2024 Oct;
PMID: 39466581
Background: Anticoagulation is recommended for thromboprophylaxis after lower-limb orthopedic surgery. The suggested dosage is based on creatinine clearance (CCr) in the labels. However, most facilities only provide estimated glomerular filtration...
2.
Kanauchi N, Saito C, Nagai K, Yamada K, Kai H, Watanabe T, et al.
BMC Nephrol
. 2024 Aug;
25(1):274.
PMID: 39187778
Background: Lifestyle modifications by educational sessions are an important component of multidisciplinary treatment for chronic kidney disease (CKD). We attempted to identify the best method to teach these modifications in...
3.
Okubo R, Kondo M, Imasawa T, Saito C, Kai H, Tsunoda R, et al.
J Ren Nutr
. 2023 Oct;
34(2):161-169.
PMID: 37832838
Objective: The Chronic Kidney Disease (CKD) practice facilitation program in the Frontier of Renal Outcome Modifications in Japan study reduced cardiovascular disease (CVD) events in patients with CKD. 10-year long-term...
4.
Morishita A, Hozumi Y, Ishii H, Hokazono Y, Manuel Yosei Kikuchi C, Shimasaki M, et al.
Endocrinol Diabetes Metab Case Rep
. 2023 Jan;
2023(1).
PMID: 36602916
Summary: Hypercalcemia due to parathyroid carcinoma (PC) is safely and quickly controlled with rapidly increasing evocalcet doses. Most parathyroid carcinomas are detected because of hypercalcemia due to primary hyperparathyroidism (PHPT)....
5.
Fujii N, Hamano T, Hsu J, Imai E, Akizawa T, Nitta K, et al.
Am J Nephrol
. 2022 Feb;
53(2-3):226-239.
PMID: 35226897
Introduction: Recent studies have suggested a higher incidence of cardiovascular disease (CVD) among patients with chronic kidney disease (CKD) in the USA than in Japan. Hyperphosphatemia, a possible risk for...
6.
Okubo R, Kondo M, Hoshi S, Kai H, Saito C, Iseki K, et al.
Clin Exp Nephrol
. 2022 Jan;
26(6):601-611.
PMID: 35084644
Background: A recent cost-effectiveness analysis (CEA) study evaluated the widespread diffusion of behaviour modification intervention for patients with chronic kidney disease (CKD). Incorporating this behaviour modification intervention, comprising educational sessions...
7.
Tsuchida-Nishiwaki M, Uchida H, Takeuchi H, Nishiwaki N, Maeshima Y, Saito C, et al.
Sci Rep
. 2021 Jul;
11(1):14990.
PMID: 34294784
It is well-known that hypertension exacerbates chronic kidney disease (CKD) progression, however, the optimal target blood pressure (BP) level in patients with CKD remains unclear. This study aimed to assess...
8.
Okubo R, Kondo M, Hoshi S, Okada M, Doi M, Takahashi H, et al.
J Ren Nutr
. 2021 Mar;
31(5):484-493.
PMID: 33744060
Objectives: Chronic kidney disease (CKD) is a significant public health problem. An advanced, or innovative, CKD care system of clinical practice collaboration among general physicians (GPs), nephrologists, and other healthcare...
9.
Kataoka H, Ono K, Mochizuki T, Hanafusa N, Imai E, Hishida A, et al.
Kidney Blood Press Res
. 2019 Jun;
44(3):362-383.
PMID: 31203292
Background/aims: Cross-classification analyses are rarely reported. We investigated the prognostic factors for chronic kidney disease (CKD) progression using a body mass index (BMI)-based cross-classification approach. Methods: Patients' renal outcome (≥50%...
10.
Iimuro S, Kaneko T, Ohashi Y, Watanabe T, Nitta K, Akizawa T, et al.
Clin Exp Nephrol
. 2019 Apr;
23(7):956-968.
PMID: 30968244
Background: Chronic kidney disease is a known risk factor for end-stage renal and cardiovascular diseases. However, data are limited on the causes of hospitalization in patients with chronic kidney disease...